From the *University of Texas M.D. Anderson Cancer Center, Houston, TX; †American College of Surgeons Commission on Cancer, Chicago IL; and ‡University of Alabama at Birmingham, Birmingham AL.
The Commission on Cancer Breast Disease Site Team: Paul L. Baron, MD, FACS, Charleston Surgical Associates Charleston, SC; James L. Connolly, MD, Beth Israel Deaconess Medical Center Boston, MA; Rosemary B. Duda, MD, FACS, Beth Israel Deaconess Medical Center Boston, MA; Stephen B. Edge, MD, FACS, Roswell Park Cancer Institute Buffalo, NY; James A. Edney, MD, FACS, University of Nebraska Medical Center Omaha, NE; Suzanne Klimberg, MD, University of Arkansas Little Rock, AK; Robert R. Kuske, MD, Scottsdale Radiology Oncology Scottsdale, AZ; A. Marilyn Leitch, MD, FACS, University of Texas Southwestern Medical Center Dallas, TX; Joseph Lipscomb, PhD, Emory University Atlanta, GA; Lisa Ann Newman, MD, FACS, University of Michigan Ann Arbor, MI; Geoffrey L. Robb, MD, FACS, University of Texas MD Anderson Cancer Center Houston, TX; Edward Allen Sickles, MD, FACR, UCSF Medical Center San Francisco, CA; George Sledge, MD, University of Indiana Indianapolis, IN; Andrew Stewart, MA, The American College of Surgeons Commission on Cancer Chicago, IL; David P. Winchester, MD, FACS, Evanston Hospital Evanston, IL.
Reprints: S. Eva Singletary, MD, FACS, Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston TX 77030-4095. E-mail: [email protected].
